Published in TB and Outbreaks Week, September 9th, 2008
"While lower values of NK-cells with increased frequency of CD3(-)CD16(+) CD56(-) and CD3(-)CD16(-)CD56(+) subsets besides lower frequency of CD3(-)CD16(+) CD56(+) NK-cells was observed in TST+, unaltered levels of NK-cells with increased levels of CD3(-)CD16(+) CD56(-) NK-cells with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.